AACR 2021: Resistance to immunotherapy in patients with urothelial bladder cancer is traced to specific sets of immune cells
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
Browsing: GU Cancers
Genes and immune cells predict immunotherapy success in bladder cancer
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
Shorter radiotherapy course reduces risk of bladder cancer returning
Giving people with bladder cancer fewer but larger doses of radiation reduces the risk of…
Bladder cancer – When to use chemotherapy
In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body’s immune system…
Diagnostic imaging may increase risk of testicular cancer
Early and repeated exposures to diagnostic imaging, such as X-rays and CT scans, may increase…
Gemcitabine and daily radiotherapy for bladder preservation in muscle-invasive bladder cancer
Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for…
Dual checkpoint blockade promising as pre-surgical approach for certain patients with localised bladder cancer
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1)…
Urine-based liquid biopsy test outperforms urine cytology in detecting bladder cancer
Analysis of DNA copy number variants (CNVs) in the cells exfoliated in urine showed better…
Immunotherapy improves survival in advanced bladder cancer patients
Immunotherapy drug avelumab has been shown to significantly improve survival in patients with the most…
Proton pump inhibitors may affect responses to atezolizumab in patients with urothelial cancer
PPIs are commonly used medications for acid reflux, heartburn, and ulcers. Recent evidence indicates that…